Call to switch anti-epileptic tablet to powder amid global recall
The TGA has urged doctors prescribing the anti-epileptic vigabatrin to switch patients to oral powder sachets when issuing new scripts amid a national shortage of…
The TGA has urged doctors prescribing the anti-epileptic vigabatrin to switch patients to oral powder sachets when issuing new scripts amid a national shortage of…
The TGA has urged pregnant women to avoid pregabalin after a study linked the drug to a higher risk of major congenital malformations. The regulator…
Patients taking anti-epileptic drugs are almost twice as likely to develop Parkinson’s disease than those not taking the medication, UK researchers report. Their analysis of…
Large study using UK data examines the risk of enzyme-inducing medications.
Health officials have been criticised for refusing to add the drug to Victoria's script monitoring system.
A blanket warning across the class of antiseizure medications is not backed by evidence, the researchers say.
Older agents, however, confer no more risk than newer non-enzyme-inducing drugs, researchers find.
The largest observational study to date provides reassurance, US researchers say.
The introduction of warning labels comes as a coroner calls for the drug to be covered in real-time prescription monitoring software.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.